Literature DB >> 28328337

Advantages of a Truly Open-Access Data-Sharing Model.

Monica M Bertagnolli1, Oliver Sartor1, Bruce A Chabner1, Mace L Rothenberg1, Sean Khozin1, Charles Hugh-Jones1, David M Reese1, Martin J Murphy1.   

Abstract

Mesh：

Year:  2017        PMID： 28328337     DOI： 10.1056/NEJMsb1702054

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

1.  Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data.

Authors:  Steffen Ventz; Albert Lai; Timothy F Cloughesy; Patrick Y Wen; Lorenzo Trippa; Brian M Alexander
Journal:  Clin Cancer Res       Date:  2019-06-07       Impact factor: 12.531

2.  Ahead of Our Time: Collaboration in Modeling Then and Now.

Authors:  Renée J G Arnold; Sean Ekins
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

3.  The search for surrogate endpoints for immunotherapy trials.

Authors:  Marc Buyse; Tomasz Burzykowski; Everardo D Saad
Journal:  Ann Transl Med       Date:  2018-06

Review 4.  Future cancer research priorities in the USA: a Lancet Oncology Commission.

Authors:  Elizabeth M Jaffee; Chi Van Dang; David B Agus; Brian M Alexander; Kenneth C Anderson; Alan Ashworth; Anna D Barker; Roshan Bastani; Sangeeta Bhatia; Jeffrey A Bluestone; Otis Brawley; Atul J Butte; Daniel G Coit; Nancy E Davidson; Mark Davis; Ronald A DePinho; Robert B Diasio; Giulio Draetta; A Lindsay Frazier; Andrew Futreal; Sam S Gambhir; Patricia A Ganz; Levi Garraway; Stanton Gerson; Sumit Gupta; James Heath; Ruth I Hoffman; Cliff Hudis; Chanita Hughes-Halbert; Ramy Ibrahim; Hossein Jadvar; Brian Kavanagh; Rick Kittles; Quynh-Thu Le; Scott M Lippman; David Mankoff; Elaine R Mardis; Deborah K Mayer; Kelly McMasters; Neal J Meropol; Beverly Mitchell; Peter Naredi; Dean Ornish; Timothy M Pawlik; Jeffrey Peppercorn; Martin G Pomper; Derek Raghavan; Christine Ritchie; Sally W Schwarz; Richard Sullivan; Richard Wahl; Jedd D Wolchok; Sandra L Wong; Alfred Yung
Journal:  Lancet Oncol       Date:  2017-10-31       Impact factor: 41.316

5.  INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology.

Authors:  Sean Khozin; Richard Pazdur; Anand Shah
Journal:  Nat Rev Drug Discov       Date:  2018-04-06       Impact factor: 84.694

6.  A Call for Open-Source Cost-Effectiveness Analysis.

Authors:  Joshua T Cohen; Peter J Neumann; John B Wong
Journal:  Ann Intern Med       Date:  2017-08-29       Impact factor: 25.391

7.  Alternative models for sharing confidential biomedical data.

Authors:  Justin Guinney; Julio Saez-Rodriguez
Journal:  Nat Biotechnol       Date:  2018-05-09       Impact factor: 54.908

8.  Clinical Trial Participants' Views of the Risks and Benefits of Data Sharing.

Authors:  Michelle M Mello; Van Lieou; Steven N Goodman
Journal:  N Engl J Med       Date:  2018-06-07       Impact factor: 91.245

Review 9.  Transparency in Decision Modelling: What, Why, Who and How?

Authors:  Christopher James Sampson; Renée Arnold; Stirling Bryan; Philip Clarke; Sean Ekins; Anthony Hatswell; Neil Hawkins; Sue Langham; Deborah Marshall; Mohsen Sadatsafavi; Will Sullivan; Edward C F Wilson; Tim Wrightson
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

10.  Diagnostic Assessment of Assumptions for External Validity: An Example Using Data in Metastatic Colorectal Cancer.

Authors:  Michael A Webster-Clark; Hanna K Sanoff; Til Stürmer; Sharon Peacock Hinton; Jennifer L Lund
Journal:  Epidemiology       Date:  2019-01       Impact factor: 4.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.